Comparison of the groups treated with mirtazapine and selective serotonine reuptake inhibitors with respect to birth outcomes and severity of psychiatric disorder

References

• Goodman JH, Chenausky KL, Freeman MP. Anxiety disorders during pregnancy: a systematic review. J Clin Psychiatry. 2014;75:e1153–e1184. doi: 10.4088/JCP.14r09035
   PubMed Web of Science ®Google Scholar
• Hodgkinson S, Colantuoni E, Roberts D, et al. Depressive symptoms and birth outcomes among pregnant teenagers. J Pediatr Adolesc Gynecol. 2010;23:16–22. doi: 10.1016/j.jpag.2009.04.006
   PubMed Web of Science ®Google Scholar
• Molenaar NM, Kamperman AM, Boyce P, et al. Guidelines on treatment of perinatal depression with antidepressants: an international review. Aust N Z J Psychiatry. 2018;52(4):320–327. doi: 10.1177/0004867418762057
   PubMed Web of Science ®Google Scholar
• Jimenez-Solem E, Andersen JT, Petersen M, et al. Prevalence of antidepressant use during pregnancy in Denmark, a nation-wide cohort study. PLoS One. 2013;8(4):e63034. doi: 10.1371/journal.pone.0063034
   PubMed Web of Science ®Google Scholar
• Molenaar MN, Lambregtse-van den Berg MP, Bonsel GJ. Dispensing patterns of selective serotonin reuptake inhibitors before, during and after pregnancy: a 16-year population-based cohort study from the Netherlands. Arch Womens Ment Health. 14 February 2019 (Ahead of print).
   Google Scholar
• Gao SY, Wu QJ, Sun C, et al. Selective serotonin reuptake inhibitor use during early pregnancy and congenital malformations: a systematic review and meta-analysis of cohort studies of more than 9 million births. BMC Med. 2018;16:205. doi: 10.1186/s12916-018-1193-5
   PubMed Web of Science ®Google Scholar
• Raposa E, Hammen C, Brennan P, et al. The long-term effects of maternal depression: early childhood physical health as a pathway to offspring depression. J Adolesc Health. 2014;54:88–93. doi: 10.1016/j.jadohealth.2013.07.038
   PubMed Web of Science ®Google Scholar
• Stein A, Pearson RM, Goodman SH, et al. Effects of perinatal mental disorders on the fetus and child. Lancet. 2014;384:1800–1819. doi: 10.1016/S0140-6736(14)61277-0
   PubMed Web of Science ®Google Scholar
• Marchesi C, Ossola P, Amerio A, et al. Clinical management of perinatal anxiety disorders: a systematic review. J Affect Disord. 2016;190:543–550. doi: 10.1016/j.jad.2015.11.004
   PubMed Web of Science ®Google Scholar
• Molenaar NM, Brouwer ME, Duvekot JJ, et al. Antidepressants during pregnancy: guideline adherence and current practice amongst Dutch gynaecologists and midwives. Midwifery. 2018;61:29–35. doi: 10.1016/j.midw.2018.02.018
   Web of Science ®Google Scholar
• Abramowitz A, Miller ES, Wisner KL. Treatment options for hyperemesis gravidarum. Arch Womens Ment Health. 2017;20(3):363–372. doi: 10.1007/s00737-016-0707-4
   Web of Science ®Google Scholar
• Winterfeld U, Klinger G, Panchaud A, et al. Pregnancy outcome following maternal exposure to mirtazapine: a multicenter, prospective study. J Clin Psychopharmacol. 2015;35(3):250–259. doi: 10.1097/JCP.0000000000000309
   Web of Science ®Google Scholar
• Djulus J, Koren G, Einarson TR, et al. Exposure to mirtazapine during pregnancy: a prospective, comparative study of birth outcomes. J Clin Psychiatry. 2006;67(8):1280–1284. doi: 10.4088/JCP.v67n0817
   PubMed Web of Science ®Google Scholar
• Reefhuis J, Devine O, Friedman JM, et al. Specific SSRIs and birth defects: Bayesian analysis to interpret new data in the context of previous reports.; National birth defects Prevention study. Br Med J. 2015;8:351.
   Google Scholar
• Guideline: SSRI use during pregnancy and during lactation. Dutch Association for Obstetrics and Gynecology (Richtlijn. SSRI-gebruik in de zwangerschap en tijdens de lactatie. Nederlandse Vereniging voor Obstetrie en Gynaecologie). Utrecht: NVOG; 2012.
   Google Scholar
• Grigoriadis S, VonderPorten EH, Mamisashvili L, et al. The impact of maternal depression during pregnancy on perinatal outcomes: a systematic review and meta-analysis. J Clin Psychiatry. 2013;74:375–376. doi: 10.4088/JCP.13com08407
   Web of Science ®Google Scholar
• Guy W. ECDEU assessment manual for psychopharmacology. Rockville (MD): US Department of Heath,Education, and Welfare Public Health Service Alcohol, Drug Abuse, and Mental Health Administration; 1976.
   Google Scholar
• Busner J, Targum SD. The clinical global impressions scale: applying a research tool in clinical practice. Psychiatry (Edgmont. 2007;4(7):28–37.
   PubMedGoogle Scholar
• Spitzer RL, Micheal B, Miriam G, et al. Stuctured clinical interview for DSM-IV Axis 1 disorders (SCID-I), clinical version. Washington DC: American Psychiatric Press; 1997.
   Google Scholar
• World Health Organization. ICD-10: International statistical classification of diseases and related health problems, 10th revision. Volume 2. 2nd ed Geneva: WHO; 2004; Available at: http://www.who.int/classifications/icd/ICD-10_2nd_ed_volume2.pdf.
   Google Scholar
• The American College of Obstetricians and Gynecologists. Committee Opinion 2013 No: 579 Available at: https://www.acog.org/-/media/Committee-Opinions/Committee-on-Obstetric-Practice/co579.pdf?dmc=1&ts=20190811T2040552453.
   Google Scholar
• Hayasaka Y, Purgato M, Magni LR, et al. Dose equivalents of antidepressants: evidence-based recommendations from randomized controlled trials. J Affect Disord. 2015;180:179–184. doi: 10.1016/j.jad.2015.03.021
   PubMed Web of Science ®Google Scholar
• Räisänen S, Lehto SM, Nielsen HS, et al. Risk factors for and perinatal outcomes of major depression during pregnancy: a population-based analysis during 2002–2010 in Finland. Br Med J. 2014;4:4883.
   PubMed Web of Science ®Google Scholar
• Grote NK, Bridge JA, Gavin AR, et al. A meta-analysis of depression during pregnancy and the risk of preterm birth, low birth weight, and intrauterine growth restriction. Arch Gen Psychiatry. 2010;67:1012–1024. doi: 10.1001/archgenpsychiatry.2010.111
   PubMed Web of Science ®Google Scholar
• Venkatesh KK, Riley L, Castro VM, et al. Association of antenatal depression symptoms and antidepressant treatment with preterm birth. Obstet Gynecol. 2016;127:926–933. doi: 10.1097/AOG.0000000000001397
   PubMed Web of Science ®Google Scholar
• Huang H, Coleman S, Bridge JA, et al. A meta-analysis of the relationship between antidepressant use in pregnancy and the risk of preterm birth and low birth weight. Gen Hosp Psychiatry. 2014;36:13–18. doi: 10.1016/j.genhosppsych.2013.08.002
   PubMed Web of Science ®Google Scholar
• Ross LE, Grigoriadis S, Mamisashvili L, et al. Selected pregnancy and delivery outcomes after exposure to antidepressant medication: a systematic review and meta-analysis. JAMA Psychiatry. 2013;70:436. doi: 10.1001/jamapsychiatry.2013.684
   PubMed Web of Science ®Google Scholar
• Lennestal R, Kallen B. Delivery outcome in relation to maternal use of some recently introduced antidepressants. J Clin Psychopharmacol. 2007;27(6):607–613. doi: 10.1097/jcp.0b013e31815ac4d2
   PubMed Web of Science ®Google Scholar
• Casper RC, Gilles AA, Fleisher BE, et al. Length of prenatal exposure to selective serotonin reuptake inhibitor (SSRI) antidepressants: effects on neonatal adaptation and psychomotor development. Psychopharmacology (Berl). 2011;217:211–219. doi: 10.1007/s00213-011-2270-z
   PubMed Web of Science ®Google Scholar
• Hogue AN, Temple-Cooper ME, Lagzdins M, et al. Effects of in-utero exposure to selective serotonin reuptake inhibitors and venlafaxine on term and preterm infants. J Neonatal Perinatal Med. 2017;10:371–380. doi: 10.3233/NPM-16133
   Google Scholar
• Laine K, Heikkinen T, Ekblad U, et al. Effects of exposure to selective serotonin reuptake inhibitors during pregnancy on serotonergic symptoms in newborns and cord blood monoamine and prolactin concentrations. Arch Gen Psychiatry. 2003;60:720–726. doi: 10.1001/archpsyc.60.7.720
   PubMed Web of Science ®Google Scholar
• Smit M, Wennink H, Heres M, et al. Mirtazapine in pregnancy and lactation: data from a case series. J Clin Psychopharmacol. 2015;35:163–167. doi: 10.1097/JCP.0000000000000279
   Web of Science ®Google Scholar
• Kieviet N, Hoppenbrouwers C, Dolman KM, et al. Risk factors for poor neonatal adaptation after exposure to antidepressants in utero. Acta Paediatr. 2015;104:384–391. doi: 10.1111/apa.12921
   PubMed Web of Science ®Google Scholar
• Şahingöz M, Yuksel G, Karsidag C, et al. Birth weight and preterm birth in babies of pregnant women with major depression in relation to treatment with antidepressants. J Clin Psychopharmacol. 2014;34:226–229. doi: 10.1097/JCP.0000000000000077
   Web of Science ®Google Scholar
• Yazdy MM, Mitchell AA, Louik C, et al. Use of selective serotonin-reuptake inhibitors during pregnancy and the risk of clubfoot. Epidemiology. 2014;25(6):859–865. doi: 10.1097/EDE.0000000000000157
   PubMed Web of Science ®Google Scholar
• Furu K, Kieler H, Haglund B, et al. Selective serotonin reuptake inhibitors and venlafaxine in early pregnancy and risk of birth defects: population based cohort study and sibling design. Br Med J. 2015;350:h1798–h1798. doi: 10.1136/bmj.h1798
   PubMed Web of Science ®Google Scholar
• Smit M, Dolman KM, Honig A. Mirtazapine in pregnancy and lactation- A systematic review. Eur Neuropsychopharmacol. 2016;26:126–135. doi: 10.1016/j.euroneuro.2015.06.014
   PubMed Web of Science ®Google Scholar
• Cooper WO, Willy ME, Pont SJ, et al. Increasing use of antidepressants in pregnancy. Am J Obstet Gynecol. 2007;196:544.
   Web of Science ®Google Scholar